Using lean techniques to define the platelet (PLT) transfusion process and cost-effectiveness to evaluate PLT dose transfusion strategies

Transfusion

Volumn 52, Issue 9, 2012, Pages 1957-1967

  Riley, William ^a,b   Smalley, Benjamin ^a,b   Pulkrabek, Shelley ^a,b   Clay, Mary E ^a,b   McCullough, Jeffrey ^a,b  

^a School of Public Health   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD BANK; BONE MARROW TRANSPLANTATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; PATIENT CARE; THROMBOCYTE TRANSFUSION;

BLOOD BANKS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; HUMANS; MODELS, BIOLOGICAL; PLATELET COUNT; PLATELET TRANSFUSION; POINT-OF-CARE SYSTEMS; PROGRAM EVALUATION; REFERENCE STANDARDS; STANDARD OF CARE; WORKFLOW;

EID: 84865802700     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03539.x     Document Type: Article

References (21)

1. Tunis SR, Benner J, McClellan M,. Comparative effectiveness research: policy context, methods development and research infrastructure. Stat Med 2010; 29: 1963-76.
2. Lauer MS,. The historical and moral imperatives of comparative effectiveness research. Stat Med 2010; 29: 1982-4.
3. Federal Coordinating Council. Report to the President and the Congress on comparative effectiveness research. February 17, 2010. [cited 2010 Feb 17]. Available from: URL: http://www.hhs.gov: http://www.hhs.gov/recovery/programs/ cer/execsummary.html
4. Committee on Comparative Effectiveness Research Prioritization. Initial national priorities for comparative effectiveness research. Washington (DC): The National Academies Press; 2009.
5. Slichter J, Kaufman R, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S,. Dose of prophylactic platelet transfusions and prevention of hemorrhage (the PLADO trial). NEJM 2010; 362: 600-13.
6. Hersh J, Hom E, Brecher M,. Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronoically platelet transfusion-dependent patient. Transfusion 1998; 38: 637-744.
7. Klumpp TR, Herman JH, Gaughan JP, Russo RR, Christman RA, Goldberg SL, Ackerman SJ, Bleecker GC, Mangan KF,. Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion 1999; 39: 674-81.
8. Goodnough L, Kuter D, McCullough J,. Prophylactic platelet transfusions from healthy normal apheresis platelet donors undergoing treatment with thrombopoietin. Blood 2001; 97: 1346-51.
9. Heddle NM, Cook RJ, Tinmouth A, Kouroukis CT, Hervig T, Klapper E, Brandwein JM, Szczepiorkowski ZM, AuBuchon JP, Barty RL, Lee KA,; SToP Study Investigators of the BEST Collaborative. A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (StoP) to patients with thrombocytopenia. Blood 2009; 113: 1564-73.
10. Smith A, Barry R, Brubaker C,. Going lean: busting barriers to patient flow. Chicago (IL): Health Administration Press; 2008.
11. Zidel T,. A lean guide to transforming healthcare: how to implement lean principles in hospitals, medical offices, clinics and other healthcare organizations. Milwaukee (WI): American Society for Quality Press; 2006.
12. Black J, Miller D,. The Toyota way to healthcare excellence: increase efficiency and improve quality with lean. Chicago (IL): Health Administration Press; 2008.
13. Garikes R,. Lean lab design. Med Lab Obs 2004; 36: 30-4.
14. Joseph T,. Design a lean laboratory layout. Med Lab Obs 2006; 38: 24-31.
15. Rutledge J, Xu M, Simpson J,. Application of the Toyota production system improves core laboratory operations. Am J Clin Pathol 2010; 133: 24-31.
16. Persoon TJ, Zaleski S, Frerichs J,. Improving preanalytic processes using the principles of lean production (Toyota production system). Am J Clin Pathol 2006; 125: 16-25.
17. Raab S, Grzybicki D, Condel J,. Effect of lean method implementation in the histopathology section of an anatomical pathology laboratory. J Clin Pathol 2008; 61: 1193-9.
18. Zarbo R, Tuthill M, D'Angelo R, Varney R, Mahar B, Neuman C, Ormsby A,. The Henry Ford production system reduction of surgical pathology in-process misidentification defects by bar code-sepcified work process standardization. Am J Clin Pathol 2009; 131: 468-77.
19. Ohno T,. Toyota production system: beyond large-scale production. Portland (OR): Productivity, Inc.; 1988.
20. Hundrich A, Chow M, Skierczynski BA, Lu Z,. A 36-hospital time and motion study: how do medical-surgical nurses spend their time? Perm J 2008; 12: 25-34.
21. Tormey C, Sweeney J, Champion MP, Snyder E, Wu Y,. Analysis of transfusion reactions associated with prestorage-pooled platelet components. Transfusion 2009; 49: 1242-7.